Back to top
loading...

Our Best Long-Term Picks for $1

From stocks under $10... income investments... value stocks and more.

From stocks under $10... income investments... value stocks and more.

Retailer Earnings Paint Cloudy Economic Picture: Stocks to Watch

The big-box retailer weakness appears to have been widespread during the quarter. The results reinforce a narrative of stagnation amid macro uncertainty.

The big-box retailer weakness appears to have been widespread during the quarter. The results reinforce a narrative of stagnation amid macro uncertainty.

Best Rare Earth Stocks to Buy Now: November 2025

Global demand for rare earths stocks is increasing, offering exposure to a fast-growing, strategically vital sector often overlooked.

Global demand for rare earths stocks is increasing, offering exposure to a fast-growing, strategically vital sector often overlooked.

NVIDIA Earnings: Key Metrics to Watch

NVIDIA's release will wrap up the reporting cycle for the broader Mag 7 group, which overall delivered a strong performance in the Q3 cycle.

NVIDIA's release will wrap up the reporting cycle for the broader Mag 7 group, which overall delivered a strong performance in the Q3 cycle.

U.S. Outperformance in Sight? ETFs to Play Morgan Stanley's Forecast

Morgan Stanley sees U.S. equities outpacing global markets into 2026, with AI-driven gains and small-cap strength supporting its upbeat S&P 500 outlook.

Morgan Stanley sees U.S. equities outpacing global markets into 2026, with AI-driven gains and small-cap strength supporting its upbeat S&P 500 outlook.

5 Must-See Earnings Charts This Week

Don't miss out on the retailers and cybersecurity giant Palo Alto Networks, says Zacks Strategist Tracey Ryniec in the latest Zacks Earnings Allstars.

Don't miss out on the retailers and cybersecurity giant Palo Alto Networks, says Zacks Strategist Tracey Ryniec in the latest Zacks Earnings Allstars.

New Strong Buy Stocks for Nov. 19: TCMD, NPSNY, and More

This medical technology company which develops medical devices for the treatment of chronic diseases at home, has seen the Zacks Consensus Estimate for its current year earnings increase 29% over the last 60 days.

This medical technology company which develops medical devices for the treatment of chronic diseases at home, has seen the Zacks Consensus Estimate for its current year earnings increase 29% over the last 60 days.

Investment Ideas

Stocks

ETFs

Mutual Funds

Options

Earnings Analysis

More Analysis

Reported Earnings Surprises

View All
Symbol Time Expected Reported %Surprise
GDS 06:52 -0.06 0.45 +850.00
KC 07:00 -0.10 0.02 +120.00
GLBE 06:05 0.06 0.07 +16.67
WIX 05:00 1.45 1.68 +15.86
DY 07:02 3.15 3.63 +15.24

EPS Positive Surprises for Nov 19, 2025

Symbol Time Expected Reported %Surprise
LUXE 06:34 -0.28 -0.71 -153.57
NYAX 07:38 0.21 0.09 -57.14
ICCM 09:04 -0.05 -0.06 -20.00
BLSH 06:52 0.08 0.07 -12.50
VVV 07:06 0.48 0.45 -6.25

EPS Negative Surprises for Nov 19, 2025

Upcoming Earnings ESP

View More
Symbol ESP Most Accurate Estimate Consensus Estimate
NVDA 2.18% 1.27 1.24
WMT 1.15% 0.61 0.61
WSM 1.21% 1.89 1.87
TJX 2.87% 1.26 1.22

Video Commentaries